跳至主要内容
临床试验/NCT03100097
NCT03100097终止不适用

A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers

Aspen Medical Products0 个研究点目标入组 62 人开始时间: 2013年12月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
62
主要终点
40% change in Oswestry Disability Index

研究概览

简要总结

The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.

详细描述

The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • o Moderate to complete disability (baseline ODI score of 21 to 80 percent)

排除标准

  • Pregnant patients
  • Patients considering pregnancy
  • Patients in any other investigational device or drug study
  • Patients unwilling to return for follow up
  • Patients unwilling to provide access to medical claims associated with pain management.

研究组 & 干预措施

Intervention (Aspen Horizon 627 LSO)

Experimental

Patients receive a lumbar brace, Aspen Horizon 627 LSO, in addition to normal medical management

干预措施: Aspen Horizon 627 LSO (Device)

Medical Management

No Intervention

Normal medical management

结局指标

主要结局

40% change in Oswestry Disability Index

时间窗: 4 weeks

Oswestry Disability Index

次要结局

  • Change in Opioid utilization(4 weeks, 8 weeks, 12 weeks)
  • General Health Survey(12 weeks)
  • Number of participants with treatment-related adverse events as assessed by questionnaire(4 weeks, 8 weeks, 12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验